There is increasing interest in the role of clinical guidelines in encouraging good practice and thus generating health gain.' However, there is professional ambivalence towards guidelines, stemming mainly from uncertainty about their effectiveness2 and how best to introduce them into clinical practice. Nevertheless, a systematic review of 59 rigorous evaluations of clinical guidelines reported improvements in the process of care in 55 studies and suggested that guidelines can change clinical practice if they are appropriately developed, disseminated, and implemented.4 Furthermore, published research has begun to identify effective techniques for introducing clinical guidelines. 57 Following the recent NHS reforms, purchasers are being encouraged to introduce guidelines clarifying the roles of primary and secondary care in patient management.8
Purchasers can either collaborate with providers in developing local guidelines or adapt published guidelines for local use. The second option is more attractive since development of a scientifically valid guideline is resource intensive9 and the necessary skills are often lacking at a local level.'0 1" However, the quality of published guidelines is variable. In this paper we propose a classification to help purchasers and providers to identify scientifically valid guidelines. Elsewhere we propose a complementary classification to help both parties to ensure that guidelines change medical practice. 1" Guidelines, criteria, and standards Quality assurance is beset with problems of terminology; terms used as synonyms include guidelines, algorithms, consensus statements, criteria, protocols, and standards. For example, the term standard is commonly used in medical audit to describe "performance the auditors have set themselves to achieve." 12 However, it has also been used to describe "complex aggregations of criteria built up into a series of statements describing good clinical practice."'3 Commenting on the terminology of quality assurance, Donabedian noted that "we have used these words in so many different ways that we no longer clearly understand each other when we say them" and suggested that we need to "clarify the existing nomenclature, encrusted and misshapen though it may be."'4 Fortunately, the US Agency for Health Care Policy and Research (AHCPR) has recently agreed distinct definitions for "practice guidelines," "medical review criteria," and "standards of quality."'5 PRACTICE GUIDELINES Practice guidelines are "systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances."''5 Such guidelines expound appropriate management options for symptom clusters, conditions, or procedures with the principal aim of promoting good performance.
Guidelines are composed of elements describing different aspects of the patient's condition and the care to be given. Eddy argued that the relative importance of these elements should be based on the weight of scientific evidence linking them to the desired clinical outcome. '6 He distinguished between three levels of importance: "standards" (in his terminology) define appropriate care and should be followed in all circumstances with no flexibility for the clinician; "guidelines" should be followed in most circumstances but allow some flexibility in some circumstances; and "options" are "so flexible as to provide virtually no guidance at all." '6 Although this link between levels of importance and flexibility is helpful, Eddy Standards relate to medical review criteria rather than to guidelines. Once criteria have been selected, a desired standard of performance can be defined. The standard chosen will depend on both the relative importance of the element from which the criterion is derived and the desired "level" of performance. The ideal standard may be interpreted as the estimated level beyond which iatrogenesis occurs, and the minimal standard as the estimated level below which avoidable mortality or major morbidity occurs. We believe, however, that it is the optimal standard at which both purchasers and providers should aim; this is best interpreted as the level at which the resources devoted to fulfilling the guideline give value (to patients) for money equal to that if they were devoted to any other NHS activity.
In the management of suspected AMI, for example, the standard for a mandatory element (for example, the percentage of patients without contraindications receiving aspirin within two hours of contacting a health professional) could be as high as 99% for ideal performance, as low as 75% for minimal performance, and between 85% and 95% for optimal performance. The use of a confidence-like interval for the optimal standard acknowledges the difficulty of Requirements for medical review criteria 1 Each criterion should be easy to define* 2 Each criterion should relate to morbidity that is amenable to improvement by medical care* 3 There should be a sound scientific basis for discriminating between good and less than good performance as judged by each criterion* 4 The effects of non-medical factors on this performance should be adequately understood* 5 The criterion should yield data on enough patients for valid statistical analysis* 6 Together these criteria should span the range of morbidity covered by the guideline- 7 Together these criteria should span the range of skills required by the guidelines 8 Together these criteria should span the range of resources specified by the guidelines *Derived from Kessner et al24 tDerived from Irvine estimating the value for money of a range of alternative uses of NHS resources given the current state of the knowledge base about health service effectiveness and efficiency. It is this knowledge base that the NHS research and development programme is designed to enhance.
Factors influencing the validity of guidelines To maximise the potential health gain from guidelines it is important to ensure that they are rigorously developed and thus consistent with the available scientific evidence or, in the absence of such evidence, best clinical judgement. If those developing guidelines fail to overcome the many potential biases inherent in that development, the resulting guidelines may recommend ineffective or even dangerous clinical practice. In this paper, therefore, we propose a classification which links validity to the way in which guidelines are developed. However, this classification does not cover dissemination and implementation strategies as these are not intrinsic properties of a guideline despite their importance in determining whether guidelines achieve health gain."'a Table 1 summarises nine desirable attributes for clinical guidelines proposed by the AHCPR.'5 Although only the first of these is labelled "validity," our systematic review of clinical guidelines4 suggests that the next three attributes -reproducibility, reliability, and representative development -also affect whether or not guidelines lead to health gains when they are followed. (In other words, as others have noted in other contexts, validity, reproducibility, reliability, and representativeness are not independent attributes.)
While those developing guidelines should aim at achieving all nine attributes and focusing especially on the first four, we are conscious that these four are difficult to bring into operation, especially for purchasers and providers. Table 2 therefore identifies four practical questions that, published work suggests, have a direct, though variable, effect on validity: how evidence was identified and synthesised; how many users of guidelines and how many key disciplines were included in the guideline group; and how the guidelines were developed.
Even with the help of this Traditional unsystematic literature reviews (without explicit research strategies, explicit inclusion criteria, or formal methods of synthesising evidence) overcome some of these problems by expanding the evidence base. However, important studies may be missed if the implicit search strategies are inappropriate or incomplete. Furthermore, the lack of explicit inclusion criteria can overwhelm the reviewer with evidence of variable quality, and the lack of formal methods of synthesis create difficulties in interpreting the evidence. Thus guidelines developed after an unsystematic literature review may suffer from selection bias while providing false reassurance. Systematic reviews overcome these problems by defining search strategies and inclusion criteria -for example, for research designs. Ungraded systematic reviews use explicit standards to judge the scientific validity and clinicial applicability of evidence and thus draw conclusions only from studies that are judged methodologically sound. For example, Haynes and colleagues reviewed the literature evaluating the effectiveness of continuing medical education.30 Before starting they defined an explicit search strategy and inclusion criteria specifying a minimum standard of methodological rigour. They identified 248 potential studies published between 1970 and 1983, of which only seven studies fulfilled their inclusion criteria. This allowed them to ensure that their conclusions were based on the best scientific evidence.
Ungraded systematic reviews typically review only randomised trials, but this approach may result in important evidence from other research designs being ignored. Sackett therefore described a method of grading evidence in which studies are ranked by design -for example, level I indicates a large randomised trial with low risk of error and level V a series of cases with no control data.29 This allows those developing guidelines to grade recommendations according to the strength of evidence -for example, a grade A recommendation is supported by at least one level I study.
When contradictory results are reported by trials addressing similar issues or several trials need to be combined formal meta-analysis is The balance of disciplines within a guideline development group also has considerable influence on the recommendations. Leape and colleagues observed differences in recommendations for carotid endarterectomy between a surgical panel and a "balanced panel" comprising surgeons, neurologists, and other specialists: the surgical panel found more indications for surgery than the balanced panel.36 Scott and Black observed similar differences between surgical and mixed panels working on cholecystectomy.37 Lomas identified three reasons why guideline development groups should include representatives of all "stakeholders": firstly, the limited information available for guideline development needs to be supplemented by the interpretations of these stakeholders; secondly, legitimate conflicts over values need to be resolved; and thirdly, the successful introduction of a guideline requires that all key disciplines contribute to its development to ensure "ownership" and support.38
METHODS OF DEVELOPING GUIDELINES
There are three main methods of developing guidelines: peer groups, Delphi techniques, and consensus conferences.39 40 
